New White Paper on Digital Opinion Leaders

It seems nothing (and no one) in our modern world has escaped the changes brought on by a migration to the digital space. In the pharmaceutical and life sciences category, the key opinion leader (KOL) is no exception. Digital opinion leaders (DOLs) have taken an ever-growing role in shaping treatment and disease management discussions. COVID-19 and the global response to the pandemic has hastened the rise of DOLs by restricting in-person activities such as congresses, meetings, and even operating in a clinic.

To read more, kindly provide your name & email to access the full white paper.

More Posts

Technology is Getting Smarter

By Paul Meade, Patient Engagement Lead  It has become apparent that in order for a healthcare organization to succeed, they need to be able to

Share:

Send Us A Message